327 related articles for article (PubMed ID: 17321478)
21. Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor.
Bischoff SC; Schwengberg S; Raab R; Manns MP
J Immunol; 1997 Dec; 159(11):5560-7. PubMed ID: 9548497
[TBL] [Abstract][Full Text] [Related]
22. Dissociated human foreskin mast cells degranulate in response to anti-IgE and substance P.
Caulfield JP; el-Lati S; Thomas G; Church MK
Lab Invest; 1990 Oct; 63(4):502-10. PubMed ID: 1700194
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of human cutaneous mast cells to anaphylactic and nonimmunological stimuli.
Brzezińska-Błaszczyk E; Zalewska A
Arch Immunol Ther Exp (Warsz); 1997; 45(1):55-9. PubMed ID: 9090441
[TBL] [Abstract][Full Text] [Related]
24. The anti-anaphylactic effect of the gall of Rhus javanica is mediated through inhibition of histamine release and inflammatory cytokine secretion.
Kim SH; Park HH; Lee S; Jun CD; Choi BJ; Kim SY; Kim SH; Kim DK; Park JS; Chae BS; Shin TY
Int Immunopharmacol; 2005 Dec; 5(13-14):1820-9. PubMed ID: 16275618
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release.
He S; Aslam A; Gaça MD; He Y; Buckley MG; Hollenberg MD; Walls AF
J Pharmacol Exp Ther; 2004 Apr; 309(1):119-26. PubMed ID: 14722328
[TBL] [Abstract][Full Text] [Related]
26. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
He S; Gaça MD; Walls AF
J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
[TBL] [Abstract][Full Text] [Related]
27. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells.
Bischoff SC; Schwengberg S; Lorentz A; Manns MP; Bektas H; Sann H; Levi-Schaffer F; Shanahan F; Schemann M
Neurogastroenterol Motil; 2004 Apr; 16(2):185-93. PubMed ID: 15086872
[TBL] [Abstract][Full Text] [Related]
28. Histamine secretion from human mesenteric and adenoidal mast cells.
Brzezińska-Błaszczyk E
Arch Immunol Ther Exp (Warsz); 1992; 40(2):97-102. PubMed ID: 1284367
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
Wang XS; Lau HY
Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
[TBL] [Abstract][Full Text] [Related]
30. Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes.
Kim SH; Lee S; Kim IK; Kwon TK; Moon JY; Park WH; Shin TY
Food Chem Toxicol; 2007 Nov; 45(11):2138-44. PubMed ID: 17602813
[TBL] [Abstract][Full Text] [Related]
31. Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells.
Gilead L; Rahamim E; Ziv I; Or R; Razin E
Immunology; 1988 Apr; 63(4):669-75. PubMed ID: 3130309
[TBL] [Abstract][Full Text] [Related]
32. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues.
Gibbs BF; Wierecky J; Welker P; Henz BM; Wolff HH; Grabbe J
Exp Dermatol; 2001 Oct; 10(5):312-20. PubMed ID: 11589728
[TBL] [Abstract][Full Text] [Related]
33. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
34. Novel six-week protocol for generating functional human connective tissue-type (MC
Tam IYS; Ng CW; Tam SY; Lau HYA
Inflamm Res; 2017 Jan; 66(1):25-37. PubMed ID: 27628164
[TBL] [Abstract][Full Text] [Related]
35. Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
Yanni JM; Miller ST; Gamache DA; Spellman JM; Xu S; Sharif NA
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):541-5. PubMed ID: 9433371
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of human pulmonary mast cells obtained by bronchoalveolar lavage to immunological and nonimmunological histamine releasers.
Brezińska-Blaszcyk E; Gaik A; Rydzyński K; Szymański A
Allerg Immunol (Leipz); 1988; 34(3):169-75. PubMed ID: 2461646
[TBL] [Abstract][Full Text] [Related]
37. A novel technique for isolating functional mast cells from the heart.
Morgan LG; Levick SP; Voloshenyuk TG; Murray DB; Forman MF; Brower GL; Janicki JS
Inflamm Res; 2008 May; 57(5):241-6. PubMed ID: 18465084
[TBL] [Abstract][Full Text] [Related]
38. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression.
Kaur D; Hollins F; Woodman L; Yang W; Monk P; May R; Bradding P; Brightling CE
Allergy; 2006 Sep; 61(9):1047-53. PubMed ID: 16918506
[TBL] [Abstract][Full Text] [Related]
39. Modulatory effect of HCO3- on rat mast cell exocytosis: cross-talks between bicarbonate and calcium.
Vilariño N; Vieytes MR; Vieites JM; Botana LM
Biochem Biophys Res Commun; 1999 Jun; 260(1):71-9. PubMed ID: 10381346
[TBL] [Abstract][Full Text] [Related]
40. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines.
Yip KH; Huang Y; Waye MM; Lau HY
Int Immunopharmacol; 2008 May; 8(5):764-8. PubMed ID: 18387520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
